Trial intelligence / Profile preview

Levetiracetam for Epilepsy in Elderly

NCT07422233Phase 4Completed

Sponsor
Dermaliq
Start
Sep 2023
Primary completion
Dec 2025
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of levetiracetam in epilepsy, sponsored by Dermaliq. Started Sep 2023; status: completed.

02

Drugs

levetiracetam
03

Conditions

epilepsy

Beyond the preview

Go deeper on NCT07422233.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07422233.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call